Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GlaxoSmithKline Begins Phase 3 Melanoma Study
Motley Fool
Monday, February 4, 2013 - 11:24am
tags:
GSK, melanoma, BRAF inhibitor, dabrafenid, MEK inhibitor, trametinib
Key TB vaccine trial fails; more waiting in the wings
Reuters
Monday, February 4, 2013 - 11:23am
tags:
tuberculosis, vaccines, Aeras, MVA85A
Aveo Pharma Readies Survival Update For Kidney Cancer Drug
TheStreet.com
Monday, February 4, 2013 - 11:22am
tags:
Aveo Pharmaceutical, kidney cancer, tivozanib
3 Ways to Make Money With Zoetis (Even If You Missed the IPO)
Motley Fool
Sunday, February 3, 2013 - 12:00pm
tags:
Zoetis
Merck Earnings Call Nuggets: Outcome of IMPROVE-IT and Filing Odanacatib
Wall Street Cheat Street
Sunday, February 3, 2013 - 11:59am
tags:
Merck, Odanacatib, osteoporosis, bone cancer
Novartis Recalls OTC Cough Syrups
Motley Fool
Sunday, February 3, 2013 - 11:53am
tags:
Novartis, recalls, Triaminic, Theraflu
US exports may drive top Indian pharmaceutical companies to grow 20 per cent in 2013 BUSINESS
IBN Live, India
Sunday, February 3, 2013 - 11:51am
tags:
Foolish Preview: Gilead Earnings
Motley Fool
Sunday, February 3, 2013 - 11:41am
tags:
Gilead Sciences, earnings
Supernus Launches Oxtellar XR in the United States
Review Seeker
Sunday, February 3, 2013 - 11:40am
tags:
Supernus Pharmaceuticals, Oxtellar XR, epilepsy
Two Biotech Names Without the Microcap Roller Coaster
Motley Fool
Sunday, February 3, 2013 - 11:37am
tags:
Acadia, Depomed
What's Ahead for Exelixis?
Motley Fool
Sunday, February 3, 2013 - 11:36am
tags:
Exelixis
NPS Pharmaceuticals Chief: Why 250k-a-Year Orphan Drug is Worth It
Y Charts
Sunday, February 3, 2013 - 11:35am
tags:
Gattex, NPS Pharmaceuticals, short bowel syndrome
100% Upside on these Bio-techs
Motley Fool
Sunday, February 3, 2013 - 11:26am
tags:
Galena Biopharma, NeuVax, MannKind, Afrezza
This Week in Biotech
Motley Fool
Sunday, February 3, 2013 - 11:23am
tags:
Keryx, Vanda, Repros Therapeutics, Celsion, Zoetis
Aegerion Pharmaceuticals Expected To Take A Hit
Seeking Alpha
Saturday, February 2, 2013 - 12:05pm
tags:
Aegerion
Medical Industry Must Disclose Doctor Payments, U.S. Says
Bloomberg
Saturday, February 2, 2013 - 12:04pm
tags:
Affordable Care Act
Zoetis Plans to Keep Factories as It Seeks New Products
Bloomberg
Saturday, February 2, 2013 - 12:03pm
tags:
Zoetis
Pfizer, Bristol-Myers, Johnson And Johnson: Do They Have The Next Plavix, Or Vioxx?
Seeking Alpha
Saturday, February 2, 2013 - 12:02pm
tags:
JNJ, Bristol-Myers Squibb, Pfizer
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against Keryx Biopharmaceuticals, Inc.
Yahoo/PR Newswire
Saturday, February 2, 2013 - 12:00pm
tags:
Keryx, lawsuit
Animal Health Firm Zoetis Is Biggest IPO Since Facebook
Motley Fool
Saturday, February 2, 2013 - 11:59am
tags:
Zoetis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.